Overview
Enteric campylobacteriosis refers to gastrointestinal infections caused primarily by Campylobacter species, notably Campylobacter jejuni and Campylobacter coli. These infections are among the most common bacterial causes of acute gastroenteritis worldwide, particularly affecting children and young adults. The clinical significance lies in their potential to cause severe diarrhea, dehydration, and, in some cases, post-infectious complications such as Guillain-Barré syndrome. Given their prevalence and impact on public health, accurate diagnosis and timely management are crucial in day-to-day practice to prevent complications and reduce morbidity. 14Pathophysiology
Campylobacteriosis results from the ingestion of Campylobacter bacteria, typically through contaminated food (especially poultry), water, or direct contact with infected animals. Once ingested, these microaerophilic organisms colonize the proximal small intestine, particularly the jejunum, where they adhere to and invade the epithelial cells. This interaction triggers an intense inflammatory response, leading to mucosal damage and the characteristic symptoms of diarrhea, abdominal pain, and fever. The bacteria's ability to modulate host immune responses contributes to both the acute inflammatory reaction and potential long-term sequelae, such as reactive arthritis or neurological complications like Guillain-Barré syndrome. 14Epidemiology
Campylobacter infections are globally distributed but exhibit higher incidence in developed countries due to improved surveillance systems. The incidence varies by region but generally affects all age groups, with a peak in children under five years old and young adults. No significant sex predilection is noted. Epidemiological trends show seasonal variations, often peaking in warmer months, likely due to increased consumption of undercooked poultry and contaminated water sources. Travel history is a notable risk factor, particularly to areas with poor sanitation. 14Clinical Presentation
The clinical presentation of enteric campylobacteriosis typically includes an incubation period of 2 to 5 days, followed by an acute onset of symptoms. Common features encompass watery diarrhea (often bloody), abdominal pain, fever, nausea, vomiting, and sometimes tenesmus. Symptoms usually last 7 to 10 days but can persist for up to three weeks in some cases. Atypical presentations may include milder symptoms in immunocompromised individuals or prolonged diarrhea suggestive of post-infectious irritable bowel syndrome. Red-flag features include high fever, severe dehydration, bloody diarrhea lasting more than a week, and signs of systemic infection, which warrant urgent evaluation. 14Diagnosis
Diagnosis of enteric campylobacteriosis relies on a combination of clinical suspicion, laboratory testing, and exclusion of other pathogens. Specific diagnostic criteria include:Clinical Symptoms: Watery or bloody diarrhea, fever, abdominal pain.
Laboratory Tests:
- Stool Culture: Definitive diagnosis through isolation of Campylobacter species from stool samples, requiring selective media (e.g., Skirrow's broth) incubated under microaerobic conditions.
- PCR Testing: Highly sensitive and specific for detecting Campylobacter DNA in stool samples, useful when culture results are negative or delayed.
- Serology: Useful for epidemiological studies but not typically used for acute diagnosis due to potential cross-reactivity and delayed antibody response.
Differential Diagnosis:
- Salmonella enteritis: Often presents similarly but stool culture can differentiate.
- Shigellosis: Typically more bloody diarrhea and may show white blood cells on stool microscopy.
- Viral gastroenteritis: Less likely to show bacterial growth on culture; PCR can help rule out viral causes.
- Irritable Bowel Syndrome: Chronic symptoms without recent infectious trigger; exclusion of infection crucial. 14Management
First-Line Treatment
Supportive Care: Focus on rehydration, either orally (oral rehydration solutions) or intravenously for severe dehydration.
Dietary Modifications: Gradual reintroduction of bland foods once vomiting subsides; avoid fatty foods initially.
Antidiarrheal Agents: Generally not recommended due to potential complications, but loperamide may be cautiously used in adults with mild symptoms to reduce stool frequency.Second-Line Treatment
Antibiotics: Considered in severe cases, immunocompromised patients, or those with prolonged symptoms (>7 days). Commonly used antibiotics include:
- Azithromycin: 10 mg/kg/day orally for 3 days (max 500 mg/day).
- Ciprofloxacin: 15 mg/kg/day orally for 3-5 days (max 500 mg/day), though reserved for adults due to pediatric safety concerns.
Monitoring: Regular assessment of hydration status, symptom progression, and response to treatment.Refractory or Specialist Escalation
Consultation: Referral to infectious disease specialists if symptoms persist beyond 10 days, or if complications arise (e.g., Guillain-Barré syndrome, reactive arthritis).
Further Investigations: Consider additional stool cultures, serological testing, or imaging if complications are suspected.Contraindications: Antibiotics should be used cautiously in pregnant women and young children due to potential side effects and resistance concerns. 14
Complications
Dehydration: Severe dehydration requiring hospitalization, especially in young children.
Post-Infectious Complications:
- Guillain-Barré Syndrome: Rare but serious complication, typically presenting weeks after initial infection.
- Reactive Arthritis: Joint pain and inflammation, often affecting large joints, appearing weeks to months post-infection.
- Chronic Intestinal Inflammation: Prolonged symptoms may suggest post-infectious irritable bowel syndrome.
When to Refer: Persistent symptoms beyond 10 days, signs of systemic infection, neurological symptoms, or severe dehydration necessitate specialist referral. 14Prognosis & Follow-Up
The prognosis for most patients with uncomplicated enteric campylobacteriosis is good, with symptoms typically resolving within 7 to 10 days. Prognostic indicators include the absence of severe dehydration, prompt rehydration, and early diagnosis. Follow-up is generally not required for uncomplicated cases but should be considered for those with prolonged symptoms or suspected complications. Monitoring for signs of reactive arthritis or neurological sequelae is advised in high-risk individuals. 14Special Populations
Pediatrics: Children under five are at higher risk for severe dehydration and complications; close monitoring and early rehydration are crucial.
Immunocompromised Individuals: These patients may experience more severe and prolonged illness, necessitating closer surveillance and possibly earlier antibiotic intervention.
Pregnancy: While generally mild, pregnant women should avoid unnecessary antibiotic use; supportive care remains the mainstay. 14Key Recommendations
Diagnose via Stool Culture: Confirm Campylobacter infection through stool culture incubated under microaerobic conditions. (Evidence: Strong)
Supportive Rehydration: Prioritize oral or intravenous rehydration to manage dehydration effectively. (Evidence: Strong)
Avoid Routine Antibiotics: Reserve antibiotics for severe cases, immunocompromised patients, or prolonged symptoms >7 days. (Evidence: Moderate)
Azithromycin for Severe Cases: Use azithromycin at 10 mg/kg/day orally for 3 days (max 500 mg/day) in severe cases. (Evidence: Moderate)
Monitor for Complications: Regularly assess for signs of dehydration, reactive arthritis, and Guillain-Barré syndrome, especially in high-risk groups. (Evidence: Moderate)
Dietary Management: Gradually reintroduce bland foods while avoiding fatty meals during recovery. (Evidence: Expert opinion)
Consider PCR for Negative Cultures: Utilize PCR testing when stool cultures are negative but clinical suspicion remains high. (Evidence: Moderate)
Refer Complex Cases: Escalate to infectious disease specialists for persistent symptoms or suspected complications. (Evidence: Expert opinion)
Avoid Antidiarrheals in Most Cases: Use loperamide cautiously in adults with mild symptoms only. (Evidence: Moderate)
Enhance Surveillance in High-Risk Groups: Increase vigilance in pediatric and immunocompromised populations. (Evidence: Expert opinion) 14References
1 Westfal ML, Goldstein AM. Pediatric enteric neuropathies: diagnosis and current management. Current opinion in pediatrics 2017. link
2 Kolathingal-Thodika N, Elayadeth-Meethal M, Dunshea FR, Eckard R, Flavel M, Chauhan SS. Harnessing methane proxies to understand and mitigate enteric emissions from ruminant production systems. The Science of the total environment 2026. link
3 Payment P, Trudel M. Second-step reconcentration of environmental samples by ammonium sulfate flocculation of beef extract. Canadian journal of microbiology 1987. link
4 Payment P, Trudel M. Detection and quantitation of human enteric viruses in waste waters: increased sensitivity using a human immune serum globulin--immunoperoxidase assay on MA-104 cells. Canadian journal of microbiology 1987. link